North America Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type (High Myopia, Degenerative Myopia, and Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), and End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers)
The North America myopia treatment market was valued at US$ 3,938.90 million in 2022 and is expected to reach US$ 7,335.26 million by 2030; it is estimated to register a CAGR of 8.1% from 2022 to 2030.
Rising Prevalence of Myopia Fuels North America Myopia Treatment Market
The rising prevalence of myopia globally represents a significant public health concern, with increasing incidences observed among children and young adults, particularly. A recent study estimated that by 2050, nearly 50% of the world's population-or 5 billion people-will be myopic, up from the current average of 30%. The frequency of myopia is also increasing in the US; it has been reported to be 42%, nearly doubling in just three decades. Multiple factors contribute to this trend, including lifestyle changes, increased urbanization, and extensive near-work activities, such as prolonged use of digital devices and limited outdoor exposure. While genetic predisposition plays a role, environmental factors also contribute to escalating the rates of myopia substantially. The impact of these lifestyle and environmental factors has led to an enhanced understanding of the complex interplay between genetic susceptibility and environmental influences, further underscoring the need for comprehensive strategies to address this burgeoning public health issue. As the prevalence of myopia continues to rise, there is a growing emphasis on developing proactive interventions, public health campaigns, and innovative treatment approaches to mitigate the long-term implications of high myopia and its associated ocular complications, thereby emphasizing the importance of addressing this multifaceted global health challenge.
North America Myopia Treatment Market Overview
The North America myopia treatment market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America myopia treatment market. The market growth in the US will be due to factors such as the growing myopia-related occurrences of vision loss and rising incidence of distant vision impairment from untreated myopia. Furthermore, the rising government support for eye health and technological advancements are prominent factors propelling the North America market growth.
The US myopia treatment market is expected to experience significant growth in the coming years. The prevalence of myopia has been increasing in recent years, which is driving the demand for effective treatments. The US has reported a prevalence of 42%, nearly doubling in just three decades, according to data released by the Myopia Institute in 2023. Furthermore, increasing awareness about myopia is also driving market growth. For instance, the Brien Holden Vision Institute's 2024 Myopia Awareness Week has selected Review of Myopia Management as its official co-sponsor. The collaboration will assist in expanding the reach of Myopia Awareness Week, which is scheduled for domestically and internationally, May 13-19, 2024. More people are becoming aware of the risks associated with myopia, such as an increased risk of developing other eye conditions-cataracts and glaucoma. This has led to a greater demand for effective treatments that can help prevent or slow down the progression of myopia. Another factor driving the growth of the myopia treatment market in the US is the availability of advanced technologies and treatments. Various treatments for myopia are now available, including corrective lenses, orthokeratology, and pharmacological treatments. These treatments are becoming increasingly sophisticated and effective, helping drive demand for myopia treatment. Finally, the growing prevalence of myopia among children is also driving the growth of the myopia treatment market in the US. As more children are diagnosed with myopia, there is a greater need for effective treatments that can help prevent or slow down its progression. This has led to increased investment in research and development of new treatments specifically designed for children. Overall, the US myopia treatment market is expected to grow in the coming years as more people become aware of the condition and demand for effective treatments increases.
North America Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)
North America Myopia Treatment Market Segmentation
The North America myopia treatment market is categorized into type, treatment, age group, end user, and country.
Based on type, the North America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest North America myopia treatment market share in 2022.
In terms of treatment, the North America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest North America myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the North America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger North America myopia treatment market share in 2022.
Based on end user, the North America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest North America myopia treatment market share in 2022.
Based on country, the North America myopia treatment market is categorized into the US, Canada, and Mexico. The US dominated the North America myopia treatment market share in 2022.
Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Topcon Healthcare Solutions Inc, Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Eyes Vision SL, Haag-Streit AG, and Carl Zeiss AG. are some of the leading companies operating in the North America myopia treatment market.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Myopia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies
5. North America Myopia Treatment Market - Key Market Dynamics
5.1 North America Myopia Treatment Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Myopia
5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Rising Availability of Advanced Technologies for Treating the Targeted Myopia
5.5 Future Trends
5.5.1 Application of Artificial Intelligence in Myopia Treatment
5.6 Impact of Drivers and Restraints:
6. Myopia Treatment Market - North America Market Analysis
7. North America Myopia Treatment Market Analysis - by Type
7.1 High Myopia
7.1.1 Overview
7.1.2 High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
7.2.1 Overview
7.2.2 Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
7.3.1 Overview
7.3.2 Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Myopia Treatment Market Analysis - by Treatment
8.1 Low-Dose Atropine Eye Drops
8.1.1 Overview
8.1.2 Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
8.2.1 Overview
8.2.2 Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2.3 LASIK
8.2.4 PRK
8.3 Contact Lenses
8.3.1 Overview
8.3.2 Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
8.4.1 Overview
8.4.2 Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Myopia Treatment Market Analysis - by Age Group
9.1 Adult Myopia
9.1.1 Overview
9.1.2 Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
9.2.1 Overview
9.2.2 Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Myopia Treatment Market Analysis - by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
10.2.1 Overview
10.2.2 Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
10.3.1 Overview
10.3.2 Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Myopia Treatment Market - Country Analysis
11.1 North America
11.1.1 North America Myopia Treatment Market
11.1.2 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
11.1.2.1 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
11.1.2.2 US
11.1.2.3 US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.3.1 US: Myopia Treatment Market Breakdown, by Type
11.1.2.3.2 US: Myopia Treatment Market Breakdown, by Treatment
11.1.2.3.3 US: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.2.3.4 US: Myopia Treatment Market Breakdown, by Age Group
11.1.2.3.5 US: Myopia Treatment Market Breakdown, by End User
11.1.2.4 Canada
11.1.2.5 Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.5.1 Canada: Myopia Treatment Market Breakdown, by Type
11.1.2.5.2 Canada: Myopia Treatment Market Breakdown, by Treatment
11.1.2.5.3 Canada: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.2.5.4 Canada: Myopia Treatment Market Breakdown, by Age Group
11.1.2.5.5 Canada: Myopia Treatment Market Breakdown, by End User
11.1.2.6 Mexico
11.1.2.7 Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.7.1 Mexico: Myopia Treatment Market Breakdown, by Type
11.1.2.7.2 Mexico: Myopia Treatment Market Breakdown, by Treatment
11.1.2.7.3 Mexico: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.2.7.4 Mexico: Myopia Treatment Market Breakdown, by Age Group
11.1.2.7.5 Mexico: Myopia Treatment Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CooperVision Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Topcon Healthcare Solutions Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Ziemer Ophthalmic Systems AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nidek Co Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eyes Vision SL
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Haag-Streit AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Carl Zeiss AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. North America Myopia Treatment Market Segmentation
Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
Table 3. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 4. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 5. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 6. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 7. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 8. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 9. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 10. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 11. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 12. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 14. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 15. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 16. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 17. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 18. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 19. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 20. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 21. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 22. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 23. Recent Organic Growth Strategies in Myopia Treatment Market
Table 24. Recent Inorganic Growth Strategies in the Myopia Treatment Market
Table 25. Glossary of Terms, Myopia Treatment Market
List of Figures
Figure 1. North America Myopia Treatment Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Myopia Treatment Market Revenue (US$ Million), 2022-2030
Figure 5. North America Myopia Treatment Market Share (%) - by Type (2022 and 2030)
Figure 6. High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Myopia Treatment Market Share (%) - by Treatment (2022 and 2030)
Figure 10. Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. LASIK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. PRK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Myopia Treatment Market Share (%) - by Age Group (2022 and 2030)
Figure 17. Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Myopia Treatment Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Myopia Treatment Market
1. Bausch Health Companies Inc
2. Alcon AG
3. CooperVision Inc
4. Johnson & Johnson Vision Care Inc
5. Topcon Healthcare Solutions Inc
6. Ziemer Ophthalmic Systems AG
7. Nidek Co Ltd
8. Eyes Vision SL
9. Haag-Streit AG
10. Carl Zeiss AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America myopia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America myopia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America myopia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.